SPDL1 and neoplasm: Blinova E. et al. [48] showed negative correlation of sPD-L1 serum concentration and CD8 + tumor expression in subgroups of Durvalumab-treated mice that carried both primary and relapsed non-muscular invasive bladder cancer of GATA 3 and KRT 5/6 expressed subtypes.